Combination therapy for the treatment of ocular neovascular disorders
CA 2876822 C · Owner: Ophthotech Corporation · Inventors: Adamis, Anthony P.; Calias, Perry; Shima, David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention features methods for treating a patient diagnosed with or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 26, 2004 and granted November 17, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 26, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 26, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.